Shares of Alignment Healthcare, Inc. (ALHC) surged 16.15% in after-hours trading on Wednesday, following the release of its impressive second-quarter 2025 financial results. The healthcare company not only beat analyst expectations but also raised its full-year outlook, signaling strong confidence in its future performance.

Alignment Healthcare reported quarterly earnings of $0.08 per share, significantly outperforming the analyst consensus estimate of a $0.07 loss. This represents a remarkable turnaround from the $0.13 loss per share reported in the same period last year. Revenue for the quarter came in at $1.015 billion, exceeding the analyst estimate of $960.3 million and marking a 46.78% increase from the previous year's $681.29 million.

The company's strong performance was further underscored by its adjusted EBITDA of $45.913 million, which far surpassed the expected $15.8 million. In light of these robust results, Alignment Healthcare raised its full-year outlook across all key metrics. The company now projects Q3 revenue between $970 million and $985 million, with full-year revenue expectations ranging from $3.885 billion to $3.910 billion. These projections exceed the current market estimates, fueling investor optimism and contributing to the stock's significant after-hours rally.